Mycophenolate mofetil and Abiraterone acetate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Mycophenolate mofetil (mycophenolate mofetil) and Abiraterone acetate (abiraterone acetate). Common drug interactions include prostatic specific antigen increased among females and anaemia among males.
The phase IV clinical study analyzes what interactions people have when they take Mycophenolate mofetil and Abiraterone acetate. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Mycophenolate mofetil?
Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.
What is Abiraterone acetate?
Abiraterone acetate has active ingredients of abiraterone acetate. eHealthMe is studying from 6,297 Abiraterone acetate users. Check the latest studies of Abiraterone acetate.
11 people who take Mycophenolate mofetil and Abiraterone acetate together, and have interactions are studied.

What are the common drug interactions of Mycophenolate Mofetil and Abiraterone Acetate, by gender? *:
female:
- Prostatic specific antigen increased
- Spinal cord compression
- Spinal fracture (fracture in one of vertebrae)
- Abdominal compartment syndrome (increased pressure in abdomen)
- Diarrhoea
- Pneumatosis (air or gas in an abnormal location in the body)
- Small intestinal obstruction (blockage in small intestine)
- Urinary tract infection
- Volvulus (obstruction caused by twisting of the stomach or intestine)
male:
- Anaemia (lack of blood)
- Cytomegalovirus viraemia (cytomegalo virus in blood stream)
- Gastroduodenal ulcer
- Hepatic enzyme increased
- Hepatitis (inflammation of the liver)
- Accelerated idioventricular rhythm (rate of cardiac contraction)
- Cardiogenic shock (inadequate circulation of blood)
- Gastrointestinal erosion (gradual destruction of gastrointestinal tract because of the inflamed mucous membrane lining the stomach)
- Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
What are the common drug interactions of Mycophenolate Mofetil and Abiraterone Acetate, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Brain abscess
- Headache (pain in head)
- Leukocytosis (increased white blood cells)
- Nocardiosis (an infectious disease affecting either the lungs or whole body)
- Photophobia (extreme sensitivity to light)
- Pleocytosis (increased cell count)
- Pyrexia (fever)
60+:
- Anaemia (lack of blood)
- Cytomegalovirus viraemia (cytomegalo virus in blood stream)
- Gastroduodenal ulcer
- Hepatic enzyme increased
- Hepatitis (inflammation of the liver)
- Accelerated idioventricular rhythm (rate of cardiac contraction)
- Cardiogenic shock (inadequate circulation of blood)
- Gastrointestinal erosion (gradual destruction of gastrointestinal tract because of the inflamed mucous membrane lining the stomach)
- Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
What are the existing conditions these people have? *
- Prostate Cancer Metastatic: 6 people, 54.55%
- Myocarditis (inflammation of heart muscle myocardium): 5 people, 45.45%
- Cardiogenic Shock (inadequate circulation of blood): 4 people, 36.36%
- Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 2 people, 18.18%
- Metastases To Bone (cancer spreads to bone): 2 people, 18.18%
- Immunodeficiency Disorders: 2 people, 18.18%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 18.18%
- High Blood Pressure: 2 people, 18.18%
- Asthma: 2 people, 18.18%
- Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Mycophenolate mofetil and Abiraterone acetate?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Mycophenolate mofetil (93,460 reports)
- Abiraterone acetate (6,297 reports)
Browse all drug interactions of Mycophenolate mofetil and Abiraterone acetate:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Mycophenolate mofetil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Abiraterone acetate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mycophenolate mofetil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Abiraterone acetate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on mycophenolate mofetil and abiraterone acetate (the active ingredients of Mycophenolate mofetil and Abiraterone acetate, respectively), and Mycophenolate mofetil and Abiraterone acetate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Epinastine Hydrochloride cause Insomnia? - 6 seconds ago
- Eczema and Joint Range Of Motion Decreased - 25 seconds ago
- Drug interactions of Nucala and Theophylline - 37 seconds ago
- Drug interactions of Colace and Alcohol - 53 seconds ago
- Could Requip Xl cause Hallucinations? - 55 seconds ago
- Drug interactions of Prednisone and Tresiba - a minute ago
- Could Clindamycin Hydrochloride cause Muscle Function Loss? - a minute ago
- Drug interactions of Hydramine and Prochlorperazine - a minute ago
- Drug interactions of Hydramine and Singulair - a minute ago
- Could Eliquis cause Venous Pressure Jugular Increased? - a minute ago